Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing Circulating and Imaging Biomarkers Towards Personalised Radiotherapy in Lung Cancer

NCT06086574 is registered in ClinicalTrials.gov with University of Manchester as lead sponsor.

NCT NCT06086574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06086574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing Circulating and Imaging Biomarkers Towards Personalised Radiotherapy in Lung Cancer
Lead sponsor
University of Manchester
Phase
Observational
Overall status
Unknown status
Start date
March 24, 2023
Completion date
September 24, 2025
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer stage iii